ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1652

The Hidden Impact of Hyperuricemia on Immune Cell Dysfunction

Isabella Yi, Henry Ping and Qian Wang, iLab Research Institute, Mountain View, CA

Meeting: ACR Convergence 2025

Keywords: Bioinformatics, cytokines, hyperuricemia, Inflammation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: Cytokines & Cell Trafficking (1650–1655)

Session Type: Abstract Session

Session Time: 1:30PM-1:45PM

Background/Purpose: Background: Hyperuricemia, characterized by elevated serum uric acid levels, is often asymptomatic yet poses serious health risks. This study investigates how soluble monosodium urate (MSU) influences immune cell dynamics, uncovering potential immunological consequences of high uric acid levels.

Methods:

Methods: Leukocyte Reduction System (LRS) cells were cultured with or without soluble MSU at 100 μg/mL for 24 hours. Single-cell and bulk RNA sequencing was conducted to assess changes in immune cell populations, and enzyme-linked immunosorbent assays (ELISA) were utilized to measure cytokine production.

Results:

Results: MSU exposure led to significant alterations in immune cell profiles, decreasing CD8+ T cells including CD8+ TCM (T central memory), CD8+ TEM (T effector memory), and effective CD8+ T cells, monocytes and dendritic cells while increasing CD4+ T cells, Tregs, macrophages, mast cells. Importantly, MSU markedly elevated proinflammatory cytokines, including TNF-α, IL-1β. Additionally, upregulation of inhibitory immune checkpoint molecules such as CD274, PDCD1LG2, CD276, PDCD1, and ELISA showed the increased protein levels CD274 and CD276. These results indicated a shift toward an immunosuppressive state.

Conclusion: Conclusions: These findings reveal that MSU profoundly alters immune cell behavior, driving inflammation and activating immunosuppressive pathways. Asymptomatic hyperuricemia may compromise immune function, potentially diminishing cancer surveillance or inducing autoimmune conditions such as lupus. Proactive management of elevated uric acid levels is crucial for maintaining immune balance. Moreover, LRS cells serve as a valuable model for investigating immune interactions under stress, paving the way for future research into the health impacts of hyperuricemia.


Disclosures: I. Yi: None; H. Ping: None; Q. Wang: None.

To cite this abstract in AMA style:

Yi I, Ping H, Wang Q. The Hidden Impact of Hyperuricemia on Immune Cell Dysfunction [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-hidden-impact-of-hyperuricemia-on-immune-cell-dysfunction/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-hidden-impact-of-hyperuricemia-on-immune-cell-dysfunction/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology